Citadel Advisors - VOYAGER THERAPEUTICS INC ownership

VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 69 filers reported holding VOYAGER THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of VOYAGER THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$376,534
-86.7%
48,585
-80.3%
0.00%
-100.0%
Q2 2023$2,822,368
+176.5%
246,495
+86.2%
0.00%
Q1 2023$1,020,905
-7.4%
132,413
-26.7%
0.00%
Q4 2022$1,102,374
-29.6%
180,717
-31.6%
0.00%
Q3 2022$1,565,000
+104.3%
264,357
+104.1%
0.00%
Q2 2022$766,000
-59.2%
129,520
-47.5%
0.00%
Q1 2022$1,877,000
+270.2%
246,493
+31.7%
0.00%
Q4 2021$507,000
-82.1%
187,191
-82.6%
0.00%
-100.0%
Q3 2021$2,835,000
-62.5%
1,077,824
-41.1%
0.00%0.0%
Q2 2021$7,560,000
+234.8%
1,830,494
+281.8%
0.00%
Q1 2021$2,258,000
-68.7%
479,378
-52.5%
0.00%
-100.0%
Q4 2020$7,219,000
-20.4%
1,009,552
+18.8%
0.00%
-33.3%
Q3 2020$9,070,000
+33.9%
850,078
+58.3%
0.00%
+50.0%
Q2 2020$6,776,000
+468.0%
536,958
+311.6%
0.00%
Q1 2020$1,193,000
-83.3%
130,451
-74.5%
0.00%
-100.0%
Q4 2019$7,125,0000.0%510,708
+23.3%
0.00%0.0%
Q3 2019$7,125,000
+53.9%
414,047
+143.4%
0.00%
+50.0%
Q2 2019$4,630,000
+1356.0%
170,111
+924.8%
0.00%
Q1 2019$318,000
+7.1%
16,600
-47.5%
0.00%
Q4 2018$297,000
-77.1%
31,619
-53.8%
0.00%
Q3 2018$1,297,000
-9.9%
68,510
-10.6%
0.00%
-100.0%
Q1 2018$1,439,000
-9.7%
76,603
-20.2%
0.00%0.0%
Q4 2017$1,593,000
-69.1%
95,937
-61.7%
0.00%
-75.0%
Q3 2017$5,155,000250,3840.00%
Other shareholders
VOYAGER THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
TRV GP III, LLC 6,391,176$60,077,00050.34%
ARMISTICE CAPITAL, LLC 2,836,000$26,658,0002.02%
Casdin Capital, LLC 1,128,075$10,604,0001.81%
BB BIOTECH AG 2,865,841$26,939,0000.86%
HIGHLINE CAPITAL MANAGEMENT, L.P. 1,284,697$12,076,0000.81%
Aevitas Wealth Management, Inc. 48,300$454,0000.46%
GREAT POINT PARTNERS LLC 365,132$3,432,0000.43%
Patriot Financial Group Insurance Agency, LLC 61,320$576,0000.38%
HARBOURVEST PARTNERS LLC 72,726$684,0000.32%
Birchview Capital, LP 33,000$310,0000.29%
View complete list of VOYAGER THERAPEUTICS INC shareholders